- Home
- Publications
- Publication Search
- Publication Details
Title
Road to elimination of HCV: Clinical challenges in HCV management
Authors
Keywords
-
Journal
LIVER INTERNATIONAL
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-12-30
DOI
10.1111/liv.15150
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV Infection
- (2021) Kimberly Page et al. NEW ENGLAND JOURNAL OF MEDICINE
- Distribution of naturally -occurring NS5B resistance-associated substitutions in Egyptian patients with chronic Hepatitis C
- (2021) Hala Rady Ahmed et al. PLoS One
- Screening for Hepatitis C Virus Infection
- (2020) Jill Jin JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A population-based screening for hepatitis C antibodies and active infection using a point-of-care test in a low prevalence area
- (2020) Ângela Carvalho-Gomes et al. PLoS One
- Association of Direct-Acting Antiviral Therapy for Hepatitis C With After-Treatment Costs Among Medicare Beneficiaries
- (2020) Jeah Jung et al. JAMA Network Open
- The unsung heroes of the Nobel-winning hepatitis C discovery
- (2020) Heidi Ledford NATURE
- The Nobel Prize in Medicine 2020 for the Discovery of Hepatitis C Virus: Transforming Hepatology
- (2020) Thomas F. Baumert JOURNAL OF HEPATOLOGY
- Hepatitis C virus elimination: laying the foundation for achieving 2030 targets
- (2020) Gregory J. Dore et al. Nature Reviews Gastroenterology & Hepatology
- Therapy Implications of Hepatitis C Virus Genetic Diversity
- (2020) Miguel Angel Martinez et al. Viruses-Basel
- Prevalence and incidence of hepatitis C virus infection in men who have sex with men: a systematic review and meta-analysis
- (2020) Fengyi Jin et al. Lancet Gastroenterology & Hepatology
- NS5A-P32 deletion as a factor involved in virologic failure in patients receiving glecaprevir and pibrentasvir
- (2019) Hayato Uemura et al. JOURNAL OF GASTROENTEROLOGY
- Screening for hepatitis C in a general adult population in a low-prevalence area: the Tromsø study
- (2019) H. Kileng et al. BMC INFECTIOUS DISEASES
- Short duration pan‐genotypic therapy with glecaprevir‐pibrentasvir for six weeks among people with recent HCV infection
- (2019) Marianne Martinello et al. HEPATOLOGY
- Efficacy and safety of glecaprevir/pibrentasvir in renally impaired patients with chronic HCV infection
- (2019) Eric Lawitz et al. LIVER INTERNATIONAL
- NS5A-P32 Deletion in Hepatitis C Genotype 1b Infection is the Most Refractory Treatment-Mediated Amino Acid Change Exhibiting Resistance to all NS5A Inhibitors
- (2019) Hayato Hikita et al. SEMINARS IN LIVER DISEASE
- Studying the frequency of aberrant DNA methylation of APC, P14, and E-cadherin genes in HCV-related hepatocarcinogenesis
- (2018) Mohamed A. Mekky et al. Cancer Biomarkers
- Study of promoter hypomethylation profiles of RAS oncogenes in hepatocellular carcinoma derived from hepatitis C virus genotype 3a in Pakistani population
- (2018) Maria Maryam et al. JOURNAL OF MEDICAL VIROLOGY
- Challenge to overcome: Nonstructural protein 5A-P32 deletion in direct-acting antiviral-based therapy for hepatitis C virus
- (2018) Ken Sato et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials
- (2017) Ira M. Jacobson et al. GASTROENTEROLOGY
- Safety and Efficacy of Elbasvir/Grazoprevir in Patients With Hepatitis C Virus Infection and Compensated Cirrhosis: An Integrated Analysis
- (2017) Ira M. Jacobson et al. GASTROENTEROLOGY
- Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection
- (2017) Hiromitsu Kumada et al. JOURNAL OF GASTROENTEROLOGY
- Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment
- (2017) Edward Gane et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection
- (2017) Marc Bourlière et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glecaprevir + pibrentasvir (ABT493 + ABT-530) for the treatment of Hepatitis C
- (2017) Hope Hubbard et al. Expert Review of Gastroenterology & Hepatology
- Mechanisms of Hepatitis C Viral Resistance to Direct Acting Antivirals
- (2015) Asma Ahmed et al. Viruses-Basel
- Efficiency of Incorporation and Chain Termination Determines the Inhibition Potency of 2′-Modified Nucleotide Analogs against Hepatitis C Virus Polymerase
- (2014) Amy Fung et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Update on hepatitis C virus resistance to direct-acting antiviral agents
- (2014) Eva Poveda et al. ANTIVIRAL RESEARCH
- Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource
- (2013) Donald B. Smith et al. HEPATOLOGY
- Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial
- (2013) Eric Lawitz et al. LANCET INFECTIOUS DISEASES
- New therapeutic strategies in HCV: polymerase inhibitors
- (2013) Ludmila Gerber et al. LIVER INTERNATIONAL
- Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
- (2013) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
- (2013) Eric Lawitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Naturally occurring resistance mutations to inhibitors of HCV NS5A region and NS5B polymerase in DAA treatment-naïve patients
- (2013) Stefania Paolucci et al. Virology Journal
- Accumulation of refractory factors for pegylated interferon plus ribavirin therapy in older female patients with chronic hepatitis C
- (2010) Kazuaki Chayama et al. HEPATOLOGY RESEARCH
- Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect
- (2010) Min Gao et al. NATURE
- Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
- (2009) Dongliang Ge et al. NATURE
- Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
- (2009) David L. Thomas et al. NATURE
- IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
- (2009) Vijayaprakash Suppiah et al. NATURE GENETICS
- Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
- (2009) Yasuhito Tanaka et al. NATURE GENETICS
- Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patients
- (2008) Thomas Kuntzen et al. HEPATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now